Trials Offered by a Specific Doctor

DEPARTMENT OF HEMATOLOGY AND ONCOLOGY
Investigator
Dawn Hershman, MD
Phone
1 212 305 1945
Email
dlh23@cumc.columbia.edu
Dr. Hershman is a Professor of Medicine and Epidemiology with Tenure and is the Leader of the Breast Cancer Program of the Herbert Irving Comprehensive Cancer Center. She completed her medical degree at the Albert Einstein College of Medicine, and completed her internal medicine and oncology fellowship training at Columbia University Medical Center, where she served as Chief Resident. During that time she completed a Master's degree in Biostatistics at the Mailman School of Public Health. Dr. Hershman has restructured and build the BC Program to focus on integrating basic, population and clinical research and integrated the clinical program to enhance quality, innovative, multidisciplinary care Since Dr. Hershman's appointment to the faculty at Columbia University in 2001, she has developed nationally recognized expertise in breast cancer treatment, prevention, survivorship, late-effects of cancer therapy, health outcomes and health disparities research. In her first year on the faculty, she was awarded career development awards from the American Society of Clinical Oncology and the National Cancer Institute (K07). Since that time she has received research scholar grants from the American Cancer Society, Department of Defense, Susan Komen Foundation, Breast Cancer Research Foundation, AVON Foundation, and the NCI. She currently has several R01 grants, and has mentored numerous faculty members who have been granted mentored career development awards. She has a strong publication record with over 150 papers and including many in high profile journals, with many receiving national press coverage. She has several national leadership roles in oncology. Within SWOG she is the Co-Chair of the Cancer Care Delivery Committee and Vice-Chair of the SWOG NCORP. ,Within ASCO she was selected to participate in the first Leadership Development Program and has been the Chair of the Grants Selection Committee, the leader of the education tack for Health Services, she has been on the quality of care committee and the publications committee. She is on the editorial board for the Journal of Clinical Oncology and is an Associate Editor at the Journal of the National Cancer Institute. Dr. Hershman has received several awards including the highly prestigious Advanced Clinical Research Award in Breast Cancer from the American Society of Clinical Oncology, the Ewig Teaching award and the Advanced Medical Achievement Award from the Avon Foundation. She is involved in clinical trials research on a local and national level, working with many national leaders in the field. She has fostered clinical trial collaborations between HICCC and MDACC, MSKCC, DFCI, Cornell, the Fred Hutchinson Institute, USC, Yale and Roswell Park Cancer Institute.

Clinical Studies Managed By Dr. Hershman:
More InfoTitleSponsorIRB Number
DetailsUsing New Imaging Technique in Women with Breast Cancer to predict response to Neoadjuvant ChemotherapyInvestigator initiated studyAAAI0480
DetailsStudy Evaluating Everolimus with Endocrine Therapy in Breast Cancer PatientsSouthwest Oncology GroupAAAL3751
DetailsA Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS)Eastern Cooperative Oncology GroupAAAM2902
Details[CLOSED] Study of Breast Cancer and Colorectal Cancer Patients with Tingling, Pain, or Numbness after ChemotherapyInternalAAAQ2054
Details[CLOSED] Semi-Structured Interviews with Patients about Chemotherapy-Induced Peripheral Neuropathy (CIPN)Columbia University Medical CenterAAAQ7714
DetailsTrACER: Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER) for Patients Receiving ChemotherapySouthwest Oncology GroupAAAR0311
DetailsBWEL: Breast Cancer Weight Loss TrialNCI AllianceAAAR1073
DetailsThe ABC Trial: Study of Aspirin as Adjuvant Therapy for HER2 Negative Breast CancerNational Cancer InstituteAAAR7518
DetailsThe CONTRoL Trial: Cryotherapy vs. cOmpression Neuropathy TRiaL (in Breast Cancer Patients)CUMCAAAR9515